Back to EZorb Newsletter Index

 

EZorb

  

EZORB MONTHLY NEWSLETTER SEP 28, 2008

In this issue:

1. Share Success: Letters From Readers
2.

Research News: Drugs to Build Bones May Weaken Them

3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb?
 

 

 

1. Share Success: Letters From Readers 

***************************************************

Letter I: From Becky

Received at Testimonial Submit Form on Thursday, August 28, 2008 at 19:53:59

(Unedited)

 

Hi, my name is Becky and I am 54 and have had Osteoporosis since 1998 (10 years). I am so excited that EZORB has reversed my bone loss. I took two kinds of bisphosphonates for 7 years. My bone density improved slightly but my stomach irritation was so bad so I quit taking it.

 

I started taking EZORB Dec 05, I had a bone density test after 6 months and saw a decline in the bone density. I called the EZORB customer assistance and they told me to take the product at least a year, so I stuck with the EZORB waited 3 years for my next bone density test and it was worth it. I am so excited! I went from a -2.9 in my lumbar spine to a -2.5 and a -2.82 to a -2.0 in my hip (so my hip went from osteoporosis to osteopenia).

 

I have had osteoporosis since 1998 (10 years) spine was 2.2 then up to 2.9 now 2.5 hip was 3.23 now 2.0.

 

I tell everyone that has bone density problems to try this amazing product. It does work.

   

Letter II: From Tamara

Received at sharesuccess @ elixirindustry.com on Fri, 01 Aug 2008 07:17:51 -0600

(Unedited)

   

Hi, My name is Tamara and I have lupus and fibromyalgia. I was desperate, I tried everything to alleviate my flares and painful periods. Nothing worked until I tried EZorb. I have not even gone through one bottle yet and as soon as I started taking it after a few days I had so much energy and my flare ended.

 

I will continue taking this. This is completely unbelievable!

 

Thank you EZorb!

 

Letter III: From Wanda

Received at Testimonial Submit Form on Saturday, June 21, 2008 at 03:45:23

(Unedited)

 

I was in so much pain that I was about to give up working and find a surgeon to take the bone spurs out of my heels. Every step felt like blades were cutting through the bottoms of my feet. Then I found EZorb online and tried it.

 

After about a month someone at work asked me why I was in such a good mood. I suddenly noticed it was because I was in less pain. I can't thank you enough can't wait to see the results on the second bottle.

 

Thank you,

Wanda

 

Letter IV: From Dee

Received at Testimonial Submit Form on Fri, 20 Jun 2008 14:01:11 -0700

(Unedited)

 

I asked the Lord to lead me to something. I started searching the internet. I got to where I could barely walk.

 

A couple of nights ago my husband and I took a two mile walk. That's amazing. Before Ezorb, I could hardly get to the bathroom at night.

 

I have had pain for years. All at once the pain just became so unbearable. The pain got into my ankle, up into my lower leg. The Lord is so good he led me to your website. Thank you so much. Ezorb seems to be helping tremendously.

 

Dee

  

***************************************************

From the Desk of EZorb Newsletter Editor:

This newsletter is now read by over 50,000 subscribers worldwide. Success stories you contribute will have great impact on many people's life. Kindly email your story to sharesuccess @ elixirindustry.com. As always your private information will never be revealed to the public.

 

2. Research News: Drugs to Build Bones May Weaken Them

 

By TARA PARKER-POPE

 

(Related Drugs: Fosamax, Actonel, Boniva and Reclast)

 

New questions have emerged about whether long-term use of bone-building drugs for osteoporosis may actually lead to weaker bones in a small number of people who use them.

 

The concern rises mainly from a series of case reports showing a rare type of leg fracture that shears straight across the upper thighbone after little or no trauma. Fractures in this sturdy part of the bone typically result from car accidents, or in the elderly and frail. But the case reports show the unusual fracture pattern in people who have used bone-building drugs called bisphosphonates for five years or more.

 

Some patients have reported that after weeks or months of unexplained aching, their thighbones simply snapped while they were walking or standing.

 

"Many of these women will tell you they thought the bone broke before they hit the ground," said Dr. Dean G. Lorich, associate director of orthopedic trauma surgery at NewYork-Presbyterian/Weill Cornell and the Hospital for Special Surgery. Dr. Lorich and his colleagues published a study in The Journal of Orthopaedic Trauma last month reporting on 20 patients with the fracture. Nineteen had been using the bone drug Fosamax for an average of 6.9 years.

 

Last year, The Journal of Bone and Joint Surgery published a Singapore report of 13 women with low-trauma fractures, including 9 who had been on long-term Fosamax therapy.

 

The doctors emphasize that the problem appears to be rare for a class of drug that clearly prevents fractures and has been life-saving for women with severe osteoporosis. Every year, American adults suffer 300,000 hip fractures.

 

Merck, which makes Fosamax, says it will study whether the unusual fracture pattern is really more common in bone-drug users. Arthur Santora, Merck's executive director for clinical research, noted that the fracture accounted for only about 5 or 6 percent of all broken hips, while drugs like Fosamax reduced the risk for the other 95 percent.

 

The fracture pattern did not emerge in placebo-controlled studies of bone drugs. But those studies have lasted only three to five years, although follow-up studies of the drug users have lasted longer. Now that the fracture pattern has been identified, researchers expect more doctors to publish reports.

 

"I have several similar patients myself," said Dr. Susan M. Ott, associate professor of medicine at the University of Washington. "Prior to these recent articles, there were a few cases here and a few cases there, but they are kind of starting to add up."

 

Bones are in a constant state of remodeling - dissolving microscopic bits of old bone, a process called resorption, and rebuilding new bone. After age 30 or so, a woman's bones start to dissolve faster than they can be rebuilt, and after menopause she may develop thin, brittle bones that are easily broken. Bisphosphonates, including Fosamax, Procter & Gamble's Actonel and GlaxoSmithKline's Boniva, slow this process.

 

But some experts are concerned that microscopic bone cracks that result from normal wear and tear are not repaired when the bone remodeling process is suppressed. A 2001 study of beagles taking high doses of bisphosphonates found an accumulation of microscopic damage, though there was no evidence that their bones were weaker.

 

Last September, the medical journal Bone reported on a study of 66 women, financed by Eli Lilly, that showed an association between Fosamax use and an accumulation of microdamage in bones.

 

In January 2006, the medical journal Geriatrics published an unusual autobiographical case report. Dr. Jennifer Schneider, a 59-year-old physician from Tucson, wrote that she was riding a New York City subway when the train lurched. "I felt a crack and I fell," she recalled in an interview. "I knew I'd fractured my femur."

 

Dr. Schneider, who had been taking Fosamax for seven years, said she had had pain in her thigh, but X-rays and scans had not found a problem.

 

In recent years, another rare side effect has been associated with bone drugs: osteonecrosis of the jaw, in which a patient's jawbone rots and dies. Most victims are cancer patients taking a potent intravenous form of the drug, but a small number of cases from ordinary users have been reported.

 

Notably, studies suggest there is little extra benefit in taking the bone drugs more than five years. Dr. Lorich says that doctors should monitor the bone metabolism of long-term users and that some patients may want to consider taking time off the drugs. When fractures do occur, surgeons need to be alerted about long-term drug use, because the fracture may require more aggressive treatment and be slower to heal.

 

Dr. Ott says the focus should be on using bone drugs only in patients with a fracture risk of at least 3 percent over the next 10 years.

 

"Too many of these people are not getting adequate treatment that definitely is beneficial," Dr. Ott said. "My major caution is that the bisphosphonates should not be used in people who don't have a high risk of fracture."

 

Source: New York Times July 15, 2008

 

3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

 

4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ elixirindustry.com for a copy of the instructions.

 

5. What Are Others Saying About EZorb?

EZorb Calcium has restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb.

  

Back to EZorb Newsletter Index

 
 
  Copyright 2008 Elixir Industry